Skip to main content
. 2023 Nov 23;10:1294808. doi: 10.3389/fmed.2023.1294808

TABLE 2.

Demographic parameters.

Active fluid system (n = 40) Gravity fluid system (n = 38) p-value
Age 71.34 ± 7.52 69.92 ± 6.89 0.375
Patient number 28 25
Gender (Male/Female) 15(53.6%)/13(46.4%) 12(48.0%)/13(52%) 0.686
Eye (right/left) 16(40.0%)/24(60.0%) 18(47.4%)/20(52.6%) 0.512
Stage of Nucleus a
2 15(37.5%) 12(31.6%) 0.582
3 25(62.5%) 26(68.4%)
ACD (mm) 3.03 ± 0.34 3.06 ± 0.52 0.545
CCT (μm) 541.1 ± 35.2 536.5 ± 31.2 0.419
ECD (/mm2) 1213.6 ± 223.5 1256.1 ± 191.3 0.667
Pre-operative BCVA, LogMAR 0.31 ± 0.25 0.30 ± 0.25 0.903
History
FECD (stage I) 7 (17.5%) 5 (13.2%) 0.575
Glaucoma 15 (37.5%) 18 (47.4%)
PPCD 2 (5.0%) 0 (0.0%)
corneal endothelitis history 8 (20.0%) 9 (23.7%)
no history 8 (20.0%) 6 (15.9)

a nucleus grading by LOCSIII. ACD, anterior chamber depth; CCT, corneal central thickness; ECD, endothelial cell density; FECD, Fuchs endothelial corneal dystrophy; PPCD, posterior polymorphous corneal dystrophy.